Peptides

Peptide H-ILDSSEEDK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ILDSSEEDK-OH include the following: Sperm protein 17: clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond M Chiriva-Internati - International Reviews of Immunology, 2011 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.3109/08830185.2011.569903 Identification of a sperm protein 17 CTL epitope restricted by HLA-A1 M Chiriva-Internati , Z Wang - journal of cancer, 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.11486 Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients K Ait-Tahar , AP Anderson, M Barnardo - Advances in , 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2017/6527306

Custom research peptide; min purity 95%.

A synthetic peptide for use as a blocking control in assays to test for specificity of PP2447 antibody, catalog no. 70R-1269

A synthetic peptide for use as a blocking control in assays to test for specificity of COPB1 antibody, catalog no. 70R-2204

A synthetic peptide for use as a blocking control in assays to test for specificity of EIF2A antibody, catalog no. 70R-1455

Peptide H-SAEGLDASASLR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SAEGLDASASLR^-OH include the following: Highly sensitive impurity detection and identification in biologics W Jin, L Burton, S Gotta, D Simmons, K Pohl - sciex.comhttps://sciex.com/content/dam/SCIEX/tech-notes/biopharma/ruo-mkt-02-13736-a/RUO-MKT-02-13736-A_Impurity%20detection%207600%20and%20Biologics%20Explorer.pdf A supramolecular cavitand for selective chromatographic separation of peptides using LC-MS/MS: a combined in silico and experimental approach S Mekapothula , ADD Wonanke , MA Addicoat - New Journal of , 2021 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2021/nj/d0nj03555f

Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool

A synthetic peptide for use as a blocking control in assays to test for specificity of WDHD1 antibody, catalog no. 70R-7950

Peptide H-GGEIQPVSVK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GGEIQPVSVK-OH include the following: Label-free selected reaction monitoring enables multiplexed quantitation of S100 protein isoforms in cancer cells J Martaca­nez-Aguilar , MP Molloy - Journal of proteome research, 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr400251t

Peptide H-ELLELDKWASLWNWFDITNWLWYIK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ELLELDKWASLWNWFDITNWLWYIK-OH include the following: Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies Y Zhai , Z Zhong , M Zariffard, GT Spear , L Qiao - Vaccine, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X13012309 Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66. 6 G Ofek , B Zirkle, Y Yang, Z Zhu, K McKee - Journal of , 2014 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.02837-13

A synthetic peptide for use as a blocking control in assays to test for specificity of SPOPL antibody, catalog no. 70R-8869

Peptide H-SLFVLGLFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLFVLGLFL-OH include the following: Profile of elotuzumab and its potential in the treatment of multiple myeloma YC Liu, S Szmania, F van Rhee - Blood and lymphatic cancer , 2014 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/BLCTT.S49780 Immunotherapy for the treatment of multiple myeloma SH Jung , HJ Lee, MC Vo , HJ Kim, JJ Lee - Critical reviews in oncology , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1040842816302529 A novel immunogenic CS 1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma J Bae, W Song, R Smith, J Daley, YT Tai - British journal of , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2141.2012.09111.x Dendritic cells and peptide-based vaccine in multiple myeloma J Bae, RH Prabhala , NC Munshi - Advances in Biology and Therapy of , 2012 - Springerhttps://link.springer.com/chapter/10.1007/978-1-4614-5260-7_6 Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders J Bae, R Smith, J Daley, N Mimura, YT Tai - Clinical Cancer , 2012 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/18/17/4850/283647 A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients J Bae, R Prabhala , A Voskertchian, A Brown - Leukemia, 2015 - nature.comhttps://www.nature.com/articles/leu2014159 Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma J Bae, F Accardi, T Hideshima, YT Tai, R Prabhala - Leukemia, 2022 - nature.comhttps://www.nature.com/articles/s41375-021-01301-6 Pembrolizumab (anti-PD-1) Treatment Increases Anti-Tumor Activities of XBP1/CD138/CS1-Specific Cytotoxic T Lymphocytes Against Multiple Myeloma J Bae, D Keskin , YT Tai, T Hideshima, N Munshi - Blood, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006497119823832 Vaccination of multiple myeloma: Current strategies and future prospects A Allegra , G Penna, V Innao , B Greve - Critical Reviews in , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1040842815001213

Peptide substrate for the kallikrein-related peptidase 7 (KLK7), the most abundant KLK family protease in the stratum corneum (outermost layer of the epidermis). KLK family have been implicated in several key homeostatic processes and in skin diseases that feature impaired desquamation. Increased levels of KLK7, have been identified in the stratum corneum of patients with atopic dermatitis (AD). T-helper type 2 cytokines, including interleukin 4 (IL-4) and-IL-13, can stimulate expression of KLK7, suggesting a direct link between inflammation in AD and KLK7 levels.KLK7 cleaves its substrates after tyrosine or phenylalanine residues. This peptide contains a C-terminal 7-amino-4-methylcoumarin (AMC) fluorescent tag, which is quenched when linked to the peptide via the amide bond. AMC is cleaved from the peptide by KLK7, upon cleavage the AMC fluorescence is activated.

A synthetic peptide for use as a blocking control in assays to test for specificity of AGPAT2 antibody, catalog no. 70R-1770

Endostatin, a non-toxic and resistance-free compound, strongly inhibits tumor growth, angiogenesis, and metastasis with over 150-fold reduction.

A synthetic peptide for use as a blocking control in assays to test for specificity of GALT antibody, catalog no. 70R-2643